Recall due to visible particles in solution

Recall due to increased allergen activity

The Federal Office for Safety in Health Care has been informed by the Slovak authority that human WNV infection has been recorded in Slovakia.

The Federal Office for Safety in Health Care has been notified by the ECDC (European Centre for Disease Prevention and Control) that three human WNV infections have been recorded in Greece.

The Federal Office for Safety in Health Care was informed by the ECDC (European Centre for Disease Prevention and Control) that 14 human WNV infections were recorded in Italy.

The Federal Office for Safety in Health Care has been notified by the ECDC (European Centre for Disease Prevention and Control) that human WNV infection has been recorded in Italy during the current season.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease prevention and Control) that human WNV infection has been recorded in Greece during the current season.

Recall due to visible particles in solution for injection in retention samples

Recall due to defects at the contract manufacturer

Up-to-date information from the 20.06-23.06.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.